so robert, too, was admitted on april 28 to st. jude, but to the cardiac unit � which is in a separate building from that of cancer patients.
.
eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
. my profile
.
.